It has been shown that GABA A receptor blockade in the dorsomedial and ventromedial hypothalamic nuclei (DMH and VMH, respectively) induces elaborated defensive behavioural responses accompanied by antinociception, which has been utilized as an experimental model of panic attack. Furthermore, the prelimbic (PL) division of the medial prefrontal cortex (MPFC) has been related to emotional reactions and the processing of nociceptive information. The aim of the present study was to investigate the possible involvement of the PL cortex and the participation of local cannabinoid CB 1 receptors in the elaboration of panic-like reactions and in innate fear-induced antinociception. Elaborated fear-induced responses were analysed during a 10-min period in an open-field test arena. Microinjection of the GABA A receptor antagonist bicuculline into the DMH/VMH evoked panic-like behaviour and fear-induced antinociception, which was decreased by microinjection of the non-selective synaptic contact blocker cobalt chloride in the PL cortex. Moreover, microinjection of AM251 (25, 100 or 400 pmol), an endocannabinoid CB 1 receptor antagonist, into the PL cortex also attenuated the defensive behavioural responses and the antinociception that follows innate fear behaviour elaborated by DMH/VMH. These data suggest that the PL cortex plays an important role in the organization of elaborated forward escape behaviour and that this cortical area is also involved in the elaboration of innate fear-induced antinociception. Additionally, CB 1 receptors in the PL cortex modulate both panic-like behaviours and fear-induced antinociception elicited by disinhibition of the DMH/VMH through microinjection of bicuculline.
Introduction
The medial prefrontal cortex (MPFC) is a limbic system-related region subdivided into the anterior cingulate, precentral, prelimbic (PL), infralimbic (IL) and medial orbital cortices. In fact, abnormal MPFC function has been consistently implicated in human psychopathology including schizophrenia (Abbruzzese et al., 1995) , sociopathy (Damasio et al., 1990) , obsessive-compulsive disorder (Baxter et al., 1990) and depression (Bench et al., 1995) . Functionally, the MPFC of rats has been implicated in modulation of cardiovascular responses, memory, attention and emotions (Verberne and Owens, 1998; Heidbreder and Groenewegen, 2003; Resstel and Corrêa, 2006) . In addition, the MPFC plays a role in anxiety (Jinks and McGregor, 1997) , and excitotoxic lesions of both the PL and IL divisions of the MPFC cause a general reduction in fear responsiveness (Shah and Treit, 2003) in rodents. Notwithstanding several investigations over the past two decades, the exact function of the MPFC remains something of an enigma.
The heterogeneity in MPFC function reported in the literature to some extent reflects the variability of MPFC layers disrupted in a particular study. According to numerous studies in rats, the MPFC plays a role in memory (Seamans et al., 1995) , attention (Muir et al., 1996) , autonomic control (Maskati and Zbrozyna, 1989) and emotion (Frysztak and Neafsey, 1994; Morgan and LeDoux, 1995) . Moreover, it has been shown that the MPFC does not play a primary role in mediating basic fear and anxiety responses, but rather acts as an inhibitory centre by controlling neocortical regions that modulate those fear-related responses, based on complex temporal and/or contextual information processed by the cortex (Ledoux, 1996) .
It has been shown that the dorsal (d) column of periaqueductal grey matter [PAG (dPAG) ], the corpora quadrigemina, the amygdaloid complex, the anterior hypothalamus, the dorsal premammillary and the ventromedial hypothalamic (VMH) nuclei are all critically involved with these panic attack-like behaviours (Canteras, 2002; Osaki et al., 2003; Castellan-Baldan et al., 2006; Coimbra et al., 2006; da Silva et al., 2013) . Moreover, the VMH is the most densely and reciprocally connected diencephalic structure with the amygdaloid complex and dPAG. This has led to the idea that the VMH is centrally situated in an amygdala-medial hypothalamus-brainstem network that critically modulates and coordinates innate defensive behaviours (Canteras, 2002) . Corroborating this evidence, the electrical stimulation of the VMH has been shown to induce panic attack-like behaviour in both rats and cats (Wheatley, 1944; Lammers et al., 1988) .
In fact, the dorsomedial hypothalamus (DMH) and the VMH are clusters of hypothalamic subnuclei located in the diencephalon implicated in the organization of aversive information and in the elaboration of physiological reactions that follow instinctive fearrelated responses elicited by environmental threats (Freitas et al., 2009; Biagioni et al., 2012 Biagioni et al., , 2013 de Freitas et al., 2013) . It has been suggested that fearinduced emotional responses evoked by laboratory animals are at least partially organized by both the DMH and VMH (Freitas et al., 2009; Biagioni et al., 2012 Biagioni et al., , 2013 , which also produce emotional alterations in humans (Wilent et al., 2010) . In fact, Wilent et al. (2010) showed that the deep brain stimulation of VMH of humans caused a dramatic increase in anxiety, and the patient reported troubled feelings to this effect that was accompanied by hyperventilation, shortness of breath, an increase in blood pressure, an increase in heart rate (467% increase) and some nausea, symptoms related to panic attacks.
Transitory dysfunctions of γ-aminobutyric acid (GABA)ergic inputs to these nuclei elicit flight behaviour in laboratory animals (Schmitt et al., 1986; Freitas et al., 2009; Biagioni et al., 2012 Biagioni et al., , 2013 de Freitas et al., 2013) . It is known that GABA exerts a tonic inhibitory effect on neurons responsible for the elaboration of defensive behavioural responses in the DMH of rats (Shekhar and DiMicco, 1987, 1993) . In fact, chronic disruption of GABAergic inhibition in the DMH induces a panic-prone state in laboratory animals, characterized by an increase in anxiety, heart rate, blood pressure and respiration rate (DiMicco et al., 1996; Shekhar et al., 1996; Shekhar and Keim, 1997) . Additionally, dysfunction of the GABAmediated neuronal system in the hypothalamic nuclei causes panic-like responses in laboratory animals and the elaborated escape behaviour organized by both the DMH and VMH is followed by significant innate fear-induced antinociception (Freitas et al., 2009) .
Endocannabinoid CB 1 receptors (CB 1 R) are highly expressed in the ventral (v) portion of the MPFC (Herkenham et al., 1991; Tsou et al., 1998) . CB 1 R are localized on axon terminals and their mechanism is based on modulation of neurotransmitter release (Howlett, 1995; Melvin et al., 1995; Wilson and Nicoll, 2001; Egertová et al., 2003) . Microinjection of anandamide (AEA), a CB 1 R agonist, in the MPFC produced anxiolytic-like responses in rats, whereas at higher doses AEA induced anxiety-like behavioural responses. Additionally, pre-treatment with AM251, a CB 1 R antagonist, decreased only the anxiogenic effect produced by AEA (Rubino et al., 2008a, b) . These data demonstrate that the endocannabinoid system plays a role in behavioural responses.
Microinjection of AEA or the AEA transport inhibitor AM404 into the vMPFC attenuates fear-conditioned responses (Lisboa et al., 2010) , demonstrating that facilitation of CB 1 -mediated neurotransmission in the vMPFC attenuates the expression of contextual fear responses.
The MPFC can also influence the elaboration of antinociceptive processes. Microinjection of N-methyl-D-aspartate receptor agonists into the MPFC produces an elevation of the nociceptive threshold measured by tail-flick and paw-withdrawal latencies in rodents (Calejesan et al., 2000; Zhang et al., 2005) . Analysis of CB 1 R involvement in CB 1 -induced antinociception has been aided by the development of CB 1 -knockout mice (Elphick and Egertová, 2001 ). In the hotplate assay and the formalin test, CB 1 -knockout animals were hypoalgesic compared with wild-type controls (Zimmer et al., 1999) .
To show the participation of the PL division of the MPFC in the organization of both panic-like responses elaborated by the DMH/VMH and fear-induced antinociceptive processes, we investigated the effect of a transitory blockade of synapses with cobalt chloride (CoCl 2 ) in the PL cortex neurons on both panic attacklike responses induced by microinjections of bicuculline in the DMH/VMH and innate fear-induced antinociception. Additionally, to investigate whether afferent inputs to CB 1 R-positive neurons in the PL cortex modulate not only the response to noxious stimulus but also the fear-induced reaction, we investigated the effect of microinjections of three concentrations of AM251 in the PL cortex on both panic attack-like responses induced by administration of bicuculline in the DMH/VMH and innate fear-induced antinociceptive processes.
Materials and method

Animals
Male Wistar rats (Rattus norvegicus, Rodentia, Muridae), weighing 220-250 g (n = 5-9 per group), from the animal facility of Ribeirão Preto School of Medicine at the University of São Paulo (FMRP-USP) were studied. They were kept four to a cage in the experimental room for at least 48 h prior to the experiments, with free access to water and food, on a 12 h light/dark cycle (lights on 07:00 hours) at 22-23°C. The enclosure was kept under a 12 h light/dark cycle (lights on 07:00 hours) and maintained at a constant room temperature of 25 ± 1°C (40-70% humidity). All experiments were performed in accordance with the recommendation of the Commission of Ethics in Animal Experimentation of the FMRP-USP (proc. 192/2009) 
Antinociceptive procedure
Independent groups of rats (n = 5-9) had their nociception thresholds compared using the tail-flick test. Each animal was placed in a restraining apparatus (Insight, Brazil) with acrylic walls, and its tail was placed on a heating sensor (tail-flick Analgesia Instrument; Insight). The progressive heat elevation was automatically interrupted at the moment when the animal removed its tail from the apparatus. An electrical current raised the temperature of the coil (Ni/Cr alloy; 26.04 cm long × 0.02 cm diameter) at the rate of 9°C/s (Prado and Roberts, 1985) starting at room temperature (∼20°C). Small current intensity adjustments were performed, if necessary, at the beginning of the experiment to obtain three consecutive tail-flick latencies (TFL) between 2.5 and 3.5 s. If the animal did not remove its tail from the heater within 6 s, the apparatus was turned off to prevent damage to the skin. Three baseline measurements of control TFL were taken at 5-min intervals. TFL were also measured during 60 min, immediately after elaborated escape behaviour was measured.
Surgical procedure
Animals were anaesthetized with 92 mg/kg ketamine (Ketamina ® ) and 9.2 mg/kg xylazine (Dopaser ® ) and fixed in a stereotaxic frame (David Kopf, USA). A stainless steel guide cannula (outer diameter 0.6 mm, inner diameter 0.4 mm) was implanted in the diencephalon, targeting the DMH and VMH nuclei and in the telencephalon, targeting the PL division of the MPFC. The upper incisor bar was set at 3.3 mm below the interaural line, such that the skull was horizontal between bregma and lambda. The guide cannula was vertically introduced into the DMH/VMH using the following coordinates, with bregma serving as the reference: anteroposterior, −2.80 mm; mediolateral, 0.5 mm; dorsoventral, 7.8 mm. Stereotaxic coordinates for cannula implantation into the PL cortex were selected from the rat brain atlas of Paxinos and Watson (1997) : anteroposterior, +1.2 mm; anterolateral 0.5 mm; dorsoventral, 2.6 mm with a lateral inclination of 29°. The guide cannula was fixed to the skull using acrylic resin and two stainless steel screws. At the end of the surgery, each guide cannula was sealed with a stainless steel wire to protect it from obstruction.
Experimental procedure
Neurophysiological study: nonspecific synaptic blockade in the PL cortex with CoCl 2 Animals (n = 5-7) were submitted to the surgery procedure for implantation of guide cannulas targeted to the DMH/VMH and the PL cortex. Five days after surgery, each rodent had baseline nociceptive thresholds recorded by the tail-flick test. Following immediately, 200 nl 1 mM CoCl 2 or physiological saline (NaCl 0.9%) was microinjected into the PL cortex. The injection needle was linked to a 5.0 μl hand-driven syringe (Hamilton, USA) by means of a polyethylene tube. The injection was made using a thin dental needle (Mizzy, outer diameter 0.3 mm) introduced through the guide cannula until its lower end was 1 mm below the cannula tip.
Five minutes after pre-treatment of the PL cortex with either CoCl 2 or NaCl 0.9%, bicuculline (40 ng/ 200 nl) or NaCl 0.9% was microinjected into the DMH/VMH of independent groups of rodents. The rats were then placed in an open-field test arena, a circular enclosure 50 cm in diameter and 50 cm high with the floor divided into 12 sections. The following responses were recorded over 10 min using a Sony Handycam camera: exploratory behaviour, expressed as the number of crossings (four paws in a given division of the circular arena floor); the frequency and duration of rearing (upright posture); behavioural defensive reactions, expressed as the frequency and duration of rapid defensive backward movements; the frequency and duration of elaborated forward escape behaviour (running intercalated with exploratory behaviour and jumping oriented to the upper side of the arena); the frequency and duration of defensive attention (alertness, a response operationally defined as the interruption of on-going behaviour when the rodents orient themselves towards the stimulus that evokes the attentive posture and make small head movements, rear and smell the surrounding air); the frequency and duration of defensive immobility ('freezing', operationally defined as immobility accompanied by absence of other exploratory or defensive behaviours with at least two of the following autonomic reactions: urination; defecation; piloerection; exophthalmos). The nociceptive responses (recorded as TFL) were measured immediately after elaborated escape behaviour and at 10, 20, 30, 40 and 60 min after the fear-related reactions. An investigator blind to the nature of the treatment groups performed the behavioural analysis.
Neuropharmacological study: microinjection of the CB 1 R antagonist AM251 into the PL cortex Animals (n = 5-9) had their nociceptive threshold measured at baseline before implantation of guide cannulas targeted to the DMH/VMH and the PL cortex. Five days after surgery, rats were gently wrapped in a cloth and hand-held to inject 200 nl dimethyl sulfoxide (DMSO) 10% or AM251 (25, 100 and 400 pmol) into the PL cortex. After 5 min, microinjections of bicuculline methiodide (40 ng/200 nl) or NaCl 0.9% (200 nl) into the DMH/VMH were randomly given to independent groups of animals. Immediately after injection, the exploratory behaviours and defensive reactions mentioned earlier were recorded for 10 min. Each animal received a single treatment of the GABAergic antagonist. The nociceptive responses (threshold) were measured immediately after the elaborated escape behaviour and 10, 20, 30, 40 and 60 min after the fear reactions.
Histology
Upon completion of the experiments, the animals were anaesthetized with 92 mg/kg ketamine (Ketamina ® ) and 9.2 mg/kg xylazine (Dopaser ® ) perfused through the left cardiac ventricle. The blood was washed out with Tyrod's buffer (40 ml at 4°C) followed by 200 ml ice-cold 4% (w/v) paraformaldehyde in 0.1 M sodium phosphate buffer (pH 7.3) for 15 min at a pressure of 50 mm Hg. The brains were quickly removed and soaked for 4 h in fresh fixative at 4°C. After fixation, the brains were sectioned and the diencephalon was rinsed in 10% and 20% sucrose dissolved in 0.1 M sodium phosphate buffer (pH 7.3) at 4°C for at least 12 h in each solution. Tissue pieces were immersed in 2-methylbutane (Sigma), frozen on dry ice (30 s), embedded in Tissue Tek and cut on a cryostat (Leica CM 1950) . The slices were then mounted on glass slides coated with chrome alum gelatine to prevent detachment and stained in a robotic autostainer (CV 5030 Leica Autostainer) with haematoxylin-eosin to localize the positions of the guide-cannula tips according to the Paxinos and Watson (1997) stereotaxic atlas using a motorized photomicroscope (AxioImager Z1, Zeiss). Data from rats in which the guide cannula tips were located outside the DMH/VMH or the PL cortex were not included in the statistical analysis. We used a total of 91 Wistar rats, but the sites of microinjection were situated inside the PL cortex and DMH/ VMH in only 65 animals. Microinjection sites outside these structures (26 animals) reached the cingulate and the IL cortices, considering the telencephalon, and the anterior or the lateral hypothalamic nuclei, regarding the diencephalon.
Drugs
Bicuculline (40 ng/200 nl; Tocris) was microinjected into the DMH/VMH. CoCl 2 (200 nl 1 mM; Sigma) and AM251 (25, 100 or 400 pmol; Sigma) were dissolved in NaCl 0.9% and DMSO 10%, respectively, shortly before use. A peristaltic pump (Stoelting Co. ® ) was used to infuse drugs at a rate of 100 n/min.
Statistical analysis
Data from independent groups of animals submitted to neurophysiological and neuropharmacological studies were expressed as the mean ± S.E.M. of defensive fearinduced behaviour and fear-induced antinociception. Two-way analysis of variance (ANOVA) was used to analyse experiments with a perfect (2 × 2) design with the factors PL cortex pretreatments (saline or cobalt) and DMH/VMH (saline or bicuculline) treatments in the neurophysiological study. When interactions between the factors were observed, one-way ANOVA followed by Newman-Keuls' post hoc test was used to compare the effect of the cobalt pretreatment followed by DMH/VMH treatment with bicuculline on the defensive behaviour. Repeated-measures ANOVA, followed by Duncan's post hoc test was also performed to analyse the fear-induced antinociceptionrelated data. In the pharmacological study one-way ANOVA followed by Newman-Keuls' post hoc test was used to analyse the effect of PL cortex pretreatment with CB 1 antagonist receptors followed by GABA A receptor blockade in the DMH/VMH. To analyse the effect of PL cortex pretreatment with CB 1 antagonist receptors on the organization of innate fearrelated responses evoked by chemical stimulation of the DMH/VMH, data were submitted to the repeatedmeasures ANOVA, followed by Duncan's post hoc test. A Kolmogorov-Smirnov test for normal distribution of data showed a Gaussian distribution inside the intervals studied in nociceptive approaches. A p value <0.05 was considered statistically significant.
Results
Effect of synapse blockade with CoCl 2 in the PL cortex on panic-like responses
The blockade of GABAergic receptors in the DMH/ VMH by intra-diencephalic microinjection of 40 ng/ 200 nl bicuculline (saline intra-PL cortex+bicuculline intra-DMH/VMH) caused a significant increase in the exploratory and defensive behaviour when compared to the general control (saline intra-PL cortex+saline intra-DMH/VMH). Two-way ANOVA showed that there was interaction between the factors PL cortex pretreatments (saline or cobalt) and DMH/VMH (saline or bicuculline) treatments (F 1,20 varying from 3.93 to 37.15, p < 0.001) considering the defensive behavioural responses studied in the present work. One-way ANOVA followed by the Newman-Keuls post hoc test showed a significant increase in crossings (F 3,20 = 54.62, p < 0.001), in frequency (F 3,20 = 30.98, p < 0.001) and duration (F 3,20 = 25.35, p < 0.001) of rearing, in frequency (F 3,20 = 44.99, p < 0.001) and duration (F 3,20 = 14.33, p < 0.01) of defensive attention, in frequency (F 3,20 = 24.19, p < 0.001) and duration (F 3,20 = 21.20, p < 0.001) of defensive immobility, in frequency (F 3,20 = 59.18, p < 0.001) and duration (F 3,20 = 17.11, p < 0.001) of defensive backward movement, in frequency (F 3,20 = 17.27, p < 0.001) and duration (F 3,20 = 16.60, p < 0.001) of forward escape behaviour elicited by animals treated with saline intra-PL cortex+bicuculline intra-DMH/VMH when compared to the control group (saline intra-PL cortex +saline intra-DMH/VMH; Figs. 1a-h and 2a-c).
Compared to the saline intra-PL cortex+bicuculline intra-DMH/VMH-treated group, pre-treatment of the PL cortex with CoCl 2 followed by intra-DMH/ VMH bicuculline treatment decreased the frequency (F 3,20 = 44.99, p < 0.001) and duration (F 3,20 = 14.33, p < 0.01) of defensive attention (Fig. 1a, b) , the frequency (F 3,20 = 24.19, p < 0.001) and duration (F 3,20 = 21.20, p < 0.001) of defensive immobility (Fig. 1c, d) , the frequency (F 3,20 = 59.18, p < 0.001) and duration (F 3,20 = 17.11, p < 0.001) of defensive backward movement (Fig. 1e, f) , the frequency (F 3,20 = 17.27, p < 0.01) and duration (F 3,20 = 16.60, p < 0.01) of forward escape behaviour (Fig. 1g, h ), crossings (F 3,20 = 54.62, p < 0.001; Fig. 2a ), the frequency (F 3,20 = 30.98, p < 0.001) and duration (F 3,20 = 25.35, p < 0.001) of rearing (Fig. 2b, c) . Schematic representation of microinjection sites of saline or CoCl 2 in the PL cortex and saline or bicuculline into the DMH/VMH is illustrated in Fig. 3 .
Effect of synaptic blockade with CoCl 2 in the PL cortex on innate fear-induced antinociception Two-way ANOVAs showed that there was interaction between the factors PL cortex pretreatments (saline or cobalt) and DMH/VMH (saline or bicuculline) treatments (F 1,20 = 26.40, p < 0.001) considering the innate fear-induced antinociception studied in the present work. Repeated-measures ANOVA showed a significant effect of treatment (F 3,20 = 9.51, p < 0.001), time Prelimbic cortex endocannabinoid system and panic 1785 (F 9,12 = 5.72, p < 0.001] and the treatment × time interaction (F 27,32 = 9.51, p < 0.001) on the change of the nociceptive threshold induced by elaborated escape behaviour. Duncan's post hoc analyses showed significant antinociception after elaborated escape behaviour in the saline intra-PL cortex+bicuculline intra-DMH/ VMH-treated group, with 30 min duration after the defensive behaviour organized by the DMH/VMH when compared to the saline intra-PL cortex+saline intra-DMH/VMH-treated group (p < 0.001). Moreover, PL cortex pretreatment with CoCl 2 followed by intra-DMH/VMH bicuculline decreased innate fearinduced antinociception immediately after the elaborated escape behaviour, when compared with the control (saline intra-PL cortex+bicuculline intra-DMH/VMH group; p < 0.001). These data are shown in Fig. 2d .
Schematic representation of microinjection sites of saline or CoCl 2 in the PL cortex and saline or bicuculline into the DMH/VMH is illustrated in Fig. 3 . (Fig. 4a-h ), in the frequency of crossings (F 4,30 = 7.14, p < 0.001) and in the frequency (F 4,30 = 5.71, p < 0.01) and duration (F 4,30 = 5.54, p < 0.01) of rearing compared with the PL cortex DMSO 10%+intra-DMH/VMH physiological saline-treated group (F 4,30 = 5.42, p < 0.001; Fig. 5a-c) .
However, one-way ANOVA followed by NewmanKeuls post hoc test showed that AM251 (at all doses) microinjected into the PL cortex caused a significant decrease in frequency of crossing (F 4,30 = 7.14, p < 0.01), in frequency (F 4,30 = 5.71, p < 0.01) and duration (F 4,30 = 5.54, p < 0.01) of rearing when compared to the DMSO 10% intra-PL cortex+bicuculline intra-DMH/ VMH-treated group during the hypothalamic elaborated escape behaviour (Fig. 5a-c) . Post hoc analyses also showed that PL cortex pretreatment with AM251 at 100 and 400 pmol/200 nl decreased the frequency (F 4,30 = 12.37, p < 0.001) and duration (F 4,30 = 16.30, (n = 5-7). The columns represent the mean and bars represent the S.E.M. *** p < 0.001 compared to saline (PL cortex)+saline (DMH/VMH)-treated group; ### p < 0.001 compared to cobalt chloride (PL cortex)+saline (DMH/ VMH)-treated group; ++ p < 0.01; +++ p < 0.001 compared to saline (PL cortex)+bicuculline (DMH/VMH)-treated group, according to one-way analysis of variance, followed by the Newman-Keuls post hoc test.
p < 0.001) of defensive attention (Fig. 4a, b) . All doses of AM251 (25, 100 and 400 pmol/200 nl) decreased the frequency (F 4,30 = 12.00, p < 0.001) and, except the intermediate dose, the duration (F 4,30 = 9.72, p < 0.01) of defensive immobility (Fig. 4c, d) . Pretreatment of the PL cortex with AM251 at any concentration followed DMH/VMH treatment with bicuculline decreased the frequency (F 4,30 = 17.43, p < 0.001) and duration (F 4,30 = 17.55, p < 0.001) of defensive backward movement (Fig. 4e, f) and the frequency (F 4,30 = 12.27, p < 0.001) and duration (F 4,30 = 17.55, p < 0.001) of forward escape behaviour (Fig. 4g, h ) compared to the DMSO 10% intra-PL cortex+bicuculline intra-DMH/VMH-treated group. A schematic representation of the microinjection sites of DMSO 10% or AM251 in the PL cortex and saline or bicuculline microinjection in the DMH/ VMH is illustrated in Fig. 6 .
Effect of PL cortex pre-treatment with the CB 1 R antagonist AM251 on the innate fear-induced antinociception
Repeated-measures ANOVA showed a significant effect of treatment (F 4,26 = 17.45, p < 0.001), time (F 9,18 = 3.52, p < 0.05) and treatment × time interaction (F 36,66 = 3.52, p < 0.05) on the change in the nociceptive threshold induced by hypothalamic elaborated escape behaviour. Duncan's post hoc analyses showed significant antinociception after elaborated escape behaviour in the DMSO 10% intra-PL cortex+bicuculline intra-DMH/VMH-treated group for 20 min after the defensive behaviour organized by the DMH/VMH, when compared to the DMSO 10% intra-PL cortex+saline intra-DMH/VMH-treated group (p < 0.05). Moreover, one-way ANOVA followed by Duncan's post hoc tests showed significant decreases of innate fearinduced antinociception in animals pretreated in the PL cortex with all concentrations (25, 100 and 400 pmol/200 nl) of AM251 followed by bicuculline in the DMH/VMH, immediately after the elaborated escape behaviour and, at higher doses, 10 and 20 min after escape responses when compared to the saline intra-PL cortex+bicuculline intra-DMH/VMH-treated group (p < 0.05). These data are shown in Fig. 5d . A schematic representation of the microinjection sites of saline or AM251 in the PL cortex and bicuculline microinjection sites in the DMH/VMH is illustrated in Fig. 6 .
Discussion
The findings of the present study suggest that the transitory GABAergic dysfunction in the DMH/VMH caused by local administration of bicuculline, a selective GABA A receptor antagonist, evoked anxiety-and panic-like behavioural responses characterized by defensive attention, defensive immobility, risk assessment, defensive backward movement and forward escape behaviour, as well as exploratory behaviour, expressed by moderate crossings and rearing. The and ventromedial (VMH) hypothalamic nuclei on the frequency (freq) and duration of defensive attention (a and b), defensive immobility (c and d), defensive backward movement (e and f) and forward escape behaviour (g and h; n = 5-9). The columns represent the mean and bars represent the S.E.M. ### p < 0.001 compared to DMSO 10% (PL cortex)+saline (DMH/VMH)-treated group; * p < 0.05; ** p < 0.01 and *** p < 0.001 compared to DMSO 10% (PL cortex)+bicuculline (DMH/VMH)-treated group; ++, p < 0.01; +++, p < 0.001 compared to AM251 25 pmol (PL cortex)+bicuculline (DMH/VMH)-treated group, according to one-way analysis of variance, followed by the Newman-Keuls post hoc test. present findings also showed that the escape behavioural responses organized by the DMH/VMH are followed by innate fear-induced antinociceptive processes. These data are consistent with previous reports showing panic-like defensive behaviour elaborated by both the DMH and VMH (Freitas et al., 2009; Biagioni et al., 2012 Biagioni et al., , 2013 de Freitas et al., 2013) .
Interestingly, pretreatment of the PL cortex with CoCl 2 , a blocker of synaptic contacts decreased all panic-like behaviours evoked by treatment with the GABA A receptor antagonist bicuculline. GABA-mediated neurotransmission has been suggested to be involved in anxiety and panic-like defensive behaviours elaborated by the DMH (Shekhar, 1993; Shekhar et al., 1996) . There is also evidence that MPFC lesions in rats have anxiolytic-like effects in the elevated plus maze test (Lacroix et al., 2000) . The MPFC is also thought to modulate conditioned fear via the amygdaloid complex neural networks (Malin et al., 2007; Quirk et al., 2003) . Finally, it is important to note that the MPFC is not functionally unified (Heidbreder and Groenewegen, 2003) . Even if our microinjections compromised specific MPFC subfields, the anxiolytic effect reported here could be explained by damage to the ventral part of the MPFC (Sullivan and Gratton, 2002) . Therefore, selective disruption of the IL cortex is followed by anxiolytic-like behaviour and inhibition of the hypothalamus-pituitary-adrenal axis in response to stressors (Sullivan and Gratton, 2002; Herman et al., 2005) . In contrast, anxiogenic or nonexistent effects were reported after selective manipulation of the anterior cingulate and dorsal PL cortices (Herman et al., 2005; Bissiere et al., 2006) . Indeed, studies have demonstrated that acute uncontrollable stress can induce functional and morphological changes in the MPFC that may be associated with cognitive impairment, as observed in depression or post-traumatic stress disorder (PTSD; Bland et al., 2005; Miller and McEwen, 2006) .
It has been reported that the prefrontal cortex has a secondary function in terms of the neural systems related to fear-induced behaviour. However, because the findings of the present study reveal a consistent decrease of fear responses in a very wide range of innate fear-related behaviours, we suggest that this cortical region may have a more direct role in mediating anxiety-and fear-induced behaviours. This critical role possibly depends on direct connections between the PL and IL division of the MPFC and other prosencephalic, diencephalic and brainstem structures with crucial involvement in neurovegetative and behavioural patterns of defensive responses, such as the PAG, hypothalamus, dorsal raphe nucleus and ventral mesencephalic tegmental area (Terreberry and Neafsey, 1983; Neafsey et al., 1986; Sesack et al., 1989; Hurley et al., 1991; Van Eden and Buijs, 2000) .
Moreover, the PL cortex pretreatment with CoCl 2 also decreased fear-induced antinociception. Based on findings reported elsewhere and on the present results, the DMH/VMH seems to play an important role in pain modulation. Increases in nociceptive thresholds were observed after panic-like behaviours, as recently described following activation of neurons in the DMH/VMH (Freitas et al., 2009; Biagioni et al., 2012 Biagioni et al., , 2013 de Freitas et al., 2013) . Interestingly, the present findings also showed the recruitment of the PL cortex in the organization of antinociception that follows elaborated fear-induced behaviour evoked by DMH/ VMH-pre-treatment with the GABA A receptor selective antagonist bicuculline.
Brain imaging studies have shown activity in cortical areas during pain processing, suggesting that the cerebral cortex is not only the end point of pain-related pathways, but is also the origin of descending outputs that contribute to the control of pain thresholds and to modulation of the emotional aspect of pain (Jasmin et al., 2003; Petrovic et al., 2004) . One interesting pathway involves the anterior cingulate cortex (ACC) and the amygdaloid complex during pain modulation. The ACC-amygdaloid complex pathway may modulate pain-related stress and aversive responses, and also pain-related memory (Petrovic et al., 2004; Tang et al., 2005) . Transcranial magnetic stimulation of the dorsolateral prefrontal cortex increased human pain tolerance (Graff-Guerrero, et al., 2005) .
The PL and IL divisions of MPFC have direct connections with limbic structures, such as the amygdaloid complex, hypothalamic nuclei, septum, hippocampal formation and PAG (Vertes, 2004) and these structures are known to play important roles in the expression of fear and anxiety (Gray and McNaughton, 1996; LeDoux, 1992) . Considering these connections and additional psychopharmacological data, we suggest that the vMPFC (PL and IL cortices) is involved in behavioural processes related to fear and anxiety (Frysztak and Neafsey, 1991; Resstel et al., 2008) . In fact, transitory inactivation of the IL cortex with local microinjections of CoCl 2 induced anxiolytic effects in rodents submitted to contextual fear conditioning and Vogel conflict tests, although it enhanced anxiety-related responses displayed by rodents submitted to either the elevated plus maze or to the place preference test (Lisboa et al., 2010) . In contrast, PL cortex inactivation enhanced trimethylthiazoline-induced freezing in rodents (Fitzpatrick et al., 2011 ). Significant differences have been observed between the results obtained with chronic lesions of the entire MPFC (Verberne et al., 1987) and those in which only the vMPFC was reversibly blocked (Resstel et al., 2004) in studies of the involvement of the MPFC in neurovegetative responses such as cardiovascular activity. Finally, Tavares et al. (2009) showed that bilateral microinjection of 200 nl 1 mM CoCl 2 into the PL cortex increased the heart rate response associated with restraint, yet CoCl 2 injections into the IL cortex significantly reduced restraint-induced heart rate increases.
Interestingly, Fisher et al. (1998) showed that neural activity in brain regions previously associated with specific phobic patients and subjects with PTSD is also recruited during panic attacks in healthy humans. The study was performed in a healthy female volunteer participating in a fear-conditioning task. During a first (but not second) trial with electric shock presentations, the woman unexpectedly experienced a panic attack that fulfilled DSM-IV criteria. These authors concluded that panic is associated with a decrease of positron emission tomographic measurements of regional cerebral blood flow in the right orbitofrontal, anterior cingulated and anterior temporal cortices, as well as in the PL. The MPFC is also involved in aversive memory and emotion related to the symptoms of patients with PTSD. There is a decrease in blood flow in MPFC in patients with PTSD and there is an increase in PTSD symptoms and physiological reactivity following exposure to traumatic pictures and sounds (Bremner et al., 1999) . According to these authors, exposure to traumatic material in subjects with PTSD (but not non-PTSD subjects) resulted in a decrease in blood flow in the MPFC (area 25), an area postulated to play a role in emotion through inhibition of amygdala responsiveness. In fact, there is evidence provided by functional neuroimaging studies that the MPFC shows less activation or even deactivation during traumatic script-driven imagery in PTSD (Hughes and Shin, 2011) . Other reports also suggest decreased activity in the ACC in PTSD (Shin et al., 1999 (Shin et al., , 2001 ). However, during recollection and imagery of traumatic events, PTSD patients display increases in the cerebral blood flow in the orbitofrontal cortex and in the anterior temporal lobe (Shin et al, 1999) . The orbitofrontal cortex controls the internal processing of the amygdaloid complex related with emotional associations (Ghashghaei and Barbas, 2002) , whereas neurons of the PL and IL divisions of the MPFC send connections to the lateral hypothalamus (Morshedi and Meredith, 2008) . Although there are differential projections by the IL and PL cortices (Vertes, 2004) , both of these cortical areas send inputs to the orbitomedial prefrontal cortex. The IL cortex is connected to the DMH (Vertes, 2004) and there are reciprocal inputs between the IL and PL cortices.
In the present study, we also showed that the blockade of ACC CB 1 R localized in the PL cortex decreased panic-like behavioural responses and innate fearantinociception evoked by intra-DMH/VMH microinjection of bicuculline. Since the cloning of cannabinoid receptors in the early 1990s, the involvement of the endocannabinoid system in several physiological and behavioural responses has been widely demonstrated (Crippa et al., 2004; Fride, 2005; Lisboa et al., 2008) . It has also been well established that the effects of this neural system are mediated by the actions of endocannabinoids on two different receptors, CB 1 and CB 2 . CB 1 R expression has been detected in the central and peripheral nervous systems, especially in the substantia nigra, globus pallidus, cerebellum, hippocampus, cerebral cortex and dorsal root ganglion of spinal nerves (Matsuda et al., 1990) . CB 2 R expression is found predominantly, but not exclusively, in cells of the immune system, although CB 2 R expression was also detected in the cerebral cortex, striatum, thalamic nuclei, hippocampus, amygdaloid complex, substantia nigra, PAG, paratrochlear nucleus, paralemniscal nucleus, red nucleus, pontine nuclei, inferior colliculus and the parvocellular portion of the medial vestibular nucleus in the rat brain (Gong et al., 2006) .
In addition, CB 1 R are localized pre-synaptically in glutamatergic nerve terminals in the MPFC (Auclair et al., 2000) . Accordingly, CB 1 R agonists such as WIN55212-2 and CP55940 (Devane et al., 1988) decreased excitatory post-synaptic currents, whereas the CB 1 R antagonist SR141716A increased them (Auclair et al., 2000) . In agreement with these findings, systemic administration of a CB 1 R antagonist increased neuronal activation in the vMPFC (Alonso et al., 1999) . These data suggest that glutamate-mediated excitatory post-synaptic currents evoked by vMPFC neurons are tonically inhibited by endocannabinoids through CB 1 R. There is also evidence suggesting that the administration of the CB 1 R antagonist/partial agonist AM251 into the vMPFC blocks extinction of fear memory. Overall, this suggests that a CB 1 R antagonist in the vMPFC would potentially worsen PTSD. However, in the present work, this procedure inhibited escape and other defensive behavioural measures, which suggests it is panicolytic. In a recent report (Hill et al., 2011) , it was demonstrated that activation of the endocannabinoid system by activating CB 1 R decreases GABA release within the MPFC, likely increasing the output of neurons from the PL division of the MPFC to contribute to termination of stress-related responses. Therefore, the co-transmission and/or the interaction between endocannabinoids, as neuromodulators, and GABA and glutamate in the MPFC (Moreira et al., 2012; Rey et al., 2012; de Freitas et al., 2013) can explain the panicolytic effect of CB 1 R blockade into the PL division of the MPFC demonstrated in the present work.
Stress induces endocannabinoid-mediated neurotransmission in the PAG associated with analgesia that can be reversed by local CB 1 R antagonism (Hohmann, et al., 2005) . In CB 1 -mutant mice, stressinduced analgesia is selectively affected, leaving opioid analgesia unaffected (Valverde et al., 2000) . The analgesic effect of endocannabinoids requires the rostroventromedial medulla (RVM) circuitry and endocannabinoids modulate the activity of RVM pain-modulating neurons (Meng et al., 1998) , suggesting the importance of this neural system in neural bases of pain modulation. Diencephalic and brainstem structures can also be recruited during pain modulation. For example, hypothalamic nuclei provide the largest descending inputs to the PAG (Beitz, 1982) , Prelimbic cortex endocannabinoid system and panic 1793 and the lateral hypothalamus has reciprocal connections with the PAG and the nucleus raphe magnus (Aimone et al., 1988; Cameron et al., 1995a, b) . Neuroanatomical evidence suggests the existence of networks linking the DMH/VMH with areas in the midbrain tectum involved in the organization of panic attack-like responses and antinociceptive processes (Stamford, 1995; Lumb, 2004) . Moreover, retrograde double-labelling methods in brainstem structures such as the dorsal raphe nucleus and locus coeruleus (both important structures of the endogenous pain inhibitory system) have demonstrated anatomical connections with the hypothalamus (Lee et al., 2005) . Additionally, it was recently reported that innate fearelaborated or oriented behavioural responses induced by GABAergic blockade in the DMH/VMH depend on monoaminergic pathways between the dorsal raphe nucleus and locus coeruleus .
In summary, the present work suggests that the afferents to the PL cortex are directly involved in the organization of defensive responses as well as in the elaboration of innate fear-induced antinociception evoked by the pre-treatment of the DMH/VMH with bicuculline. Interestingly, it was also demonstrated that CB 1 R in the PL cortex are involved in the elaboration of panic attack-like behaviour and innate fearinduced antinociception, possibly by interacting with other neural systems, such as glutamatergic or GABAergic neurons. Finally, the reciprocal connection between the PL cortex and the DMH/VMH might exert panicogenic-like effects and may be implicated in the organization of fear-induced antinociception induced by GABA A receptor blockade in the DMH/VMH. Endocannabinoid systems play a critical role in panic attack-related defensive behaviour and innate fearinduced antinociception organized by the medial hypothalamic neurons via PL cortex-CB 1 R.
